Clicky

Cyxone AB(CYXO)

Description: Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malmö, Sweden.


Keywords: Medicine Disease Infection Monoclonal Antibodies Rheumatoid Arthritis Arthritis Multiple Sclerosis Rheumatology Treatment Of Multiple Sclerosis Connective Tissue Diseases Mor103 Tocilizumab

Home Page: www.cyxone.com

Adelgatan 21
Malmö, 221 22
Sweden
Phone: 46 7 08 88 21 72


Officers

Name Title
Mr. Carl-Magnus Hogerkorp COO & Acting CEO
Mr. Ola Skanung Chief Financial Officer
Ms. Erika Samuelsson Chief Devel. Officer

Exchange: ST

Country: SE : Sweden

Currency: Swedish krone (kr)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.9968
Price-to-Sales TTM: 5168.3467
IPO Date:
Fiscal Year End: December
Full Time Employees: 8
Back to stocks